{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

Atlas of MS report launched on 17 September 2008

On 17 September MSIF and the World Health Organization launched the Atlas of MS report.

read more

Genetics edition of MS in focus now in Dutch

Issue 8 of our biannual magazine is now available to download for free in Dutch.

read more

September 2008 MSIF Meetings update

Over 60 delegates attended MSIF’s biannual Board and Committee Meetings in Montreal, Canada, from 13 to 15 September 2008.

read more

450 attend Montréal08 – Living with MS day

On Tuesday 16 September 2008, more than 450 people, including those affected by MS, health professionals and MS society staff and volunteers from around the globe attended Montréal08 – Living with MS: Global Perspectives on Current Issues in Montreal, Canada.

read more

back to top

Profile of the Month : October 2008

Kathleen Wilson

Country: USA
Age: 50
Occupation: Founding President, MSWorld, Inc
Type of MS: Relapsing remitting
Year of diagnosis: 1988



My motto is ‘wellness is a state of mind.’ I believe that living well is a choice that we make every day and our personal happiness has everything to do with how we feel about ourselves and how we connect and share with others.

Read the full article here:

English Espanol Italiano Francais Deutsch Русский

back to top

Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis

This study showed that treatment with glatiramer, a disease modifying treatment for MS, improved fatigue and reduced days off work.

authors: Ziemssen T, Hoffmann J, Apfel R, Kern S

source: Health Qual Life Outcomes. 2008 Sep 5;6(1):67. [Epub ahead of print]

read more

Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis

This study of stem-cell therapy in an animal model of MS showed improvement of the clinical signs, inflammation and brain injury. However these changes were not due to remyelination, instead appearing to be related to a change in the immune response.

authors: Aharonowiz M, Einstein O, Fainstein N, Lassmann H, Reubinoff B, Ben-Hur T

source: PLoS ONE. 2008 Sep 5;3(9):e3145

read more

Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod

The authors researched the effects of fingolimod, a potential new oral medication for MS, in the laboratory. They looked at its effects on the cells responsible for making myelin and found that it influences their survival.

authors: Miron VE, Hall JA, Kennedy TE, Soliven B, Antel JP

source: Am J Pathol. 2008 Sep 4. [Epub ahead of print]

read more

A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis

The authors studied the composition of cell membranes in the brains of people with MS. They found changes in both white and grey matter and these depended on the activity of the disease, and might be important in causing demyelination.

authors: Wheeler D, Bandaru VV, Calabresi PA, Nath A, Haughey NJ

source: Brain. 2008 Sep 4. [Epub ahead of print]

read more

HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility

The role of genes in the pathogenesis of MS is complex. The authors found an association between some genes and the risk of developing MS.

authors: Chao MJ, Barnardo MC, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA, Montpetit A, Sadovnick AD, Knight JC, Ebers GC

source: Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13069-74

read more

back to top

EndMS campaign launched by MS Society of Canada

source: MS Society of Canada

The MS Society of Canada have launched endMS, a campaign to recruit, train, support, and retain the next generation of MS researchers in Canada, and to accelerate their research activities to find a cure and improved treatments for MS.

read more

Live progressive MS chatroom to take place on 25 September

source: The MS Trust, UK

The MS Trust, UK, runs regular chatroom sessions that allow people to address questions directly to professionals with expertise in an area of life with MS or to discuss the topic with other people in a similar situation.

read more

Moving to an era of hope and inspiration at Montréal08

source: National Multiple Sclerosis Society USA

Nearly 5,200 clinicians, clinical researchers and basic scientists gathered in Montreal, Canada, from 17 to 20 September 2008 for Montréal08, the World Congress on Treatment and Research in MS.

read more

UK Prime Minister welcomes MS Society award

source: MS Society UK

The MS Society has been recognised as the only charity in the UK to join a new awards initiative by the Fulbright Commission which aims to develop the talent of some of Britain’s most promising medical researchers.

read more

back to top

Tell a friend

The email you subscribed with us is {{print email}}

Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.